跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-321
首页
药物
AT-321
AT-321
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
VARIANT, RECOMBINANT BETA-GLUCOCEREBROSIDASE PROTEINS WITH INCREASED STABILITY AND INCREASED RETAINED CATALYTIC ACTIVITY
CN 105296447 A
申请人: CALLIDUS BIOPHARMA INC
优先权: 2010
CN
US
7 件公开
Thrombin generation inhibitors
US 7074892 B2
申请人: UNIV STATE CLEVELAND
优先权: 2001
US
4 件公开
Isolated polynucleotides and polypeptides for increasing plant yield and/or agricultural characteristics
US 9328353 B2
申请人: EMMANUEL EYAL
优先权: 2011
US
4 件公开
Isolated polynucleotides and polypeptides, and methods of using same for improving plant properties
US 9551006 B2
申请人: PORATY LIMOR
优先权: 2011
US
3 件公开
Composite materials having a low shrinkage force
US 7601767 B2
申请人: HERAEUS KUTZER GMBH
优先权: 2005
US
2 件公开
Gas mist pressure bath system
US 8905982 B2
申请人: NAKAMURA SHOICHI
优先权: 2009
US
2 件公开
Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors
US 9873661 B2
申请人: UNIV NEW YORK
优先权: 2012
US
2 件公开
Omi and domains thereof that disrupt IAP-caspase interaction
US 2003073629 A1
申请人: ALNEMRI EMAD S
优先权: 2002
US
Genes and proteins for the biosynthesis of the glycopeptide antibiotic A40926
EP 1413626 A1
申请人: VICURON PHARM INC
优先权: 2002
EP
Human Coagulation Factor VII Polypeptides
US 2009055942 A1
申请人: NOVO NORDISK HEALTHCARE AG
优先权: 2006
US
第 1 / 2 页
上一页
下一页
药物
反馈